Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

Nolan, L, Johnson, P W M, Ganesan, A ORCID: https://orcid.org/0000-0003-4862-7999, Packham, G and Crabb, S J (2008) Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential? British Journal of Cancer, 99 (5). pp. 689-694. ISSN 0007-0920

Full text not available from this repository.

Abstract

Histone deacetylase inhibitors have progressed rapidly from the laboratory to clinical testing. This review highlights the promising data for their combination with a wide range of established and novel anticancer agents and discusses the mechanisms that underpin these interactions.

Item Type:	Article
Faculty \ School:	Faculty of Science > School of Pharmacy (former - to 2024) Faculty of Social Sciences > School of Education and Lifelong Learning
UEA Research Groups:	Faculty of Science > Research Groups > Chemical Biology and Medicinal Chemistry (former - to 2021)
Depositing User:	Users 2731 not found.
Date Deposited:	20 Oct 2011 11:44
Last Modified:	24 Sep 2024 09:34
URI:	https://ueaeprints.uea.ac.uk/id/eprint/35116
DOI:	10.1038/sj.bjc.6604557

Actions (login required)

View Item